Neuro-Oncology
Neuro-Oncology
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
4
Clinical Trials
Neuro-Oncology
Phase II
Enrolling
nct/study# NCT05859334 / 10559
A Phase 2 Study of Erdafitinib in Patients with Recurrent or Progressive IDH-Wild Type Glioma with an FGFR-TACC Gene Fusion
Learn More
Neuro-Oncology
Phase III
Enrolling
nct/study# NCT06556563 / EF-41-KEYNOTE-D58
Tumor Treating Fields (TTFields) with maintenance temozolomide (TMZ) and pembrolizumab versus TTFields concomitant with maintenance TMZ and placebo in participants with newly diagnosed glioblastoma. Keynote D58
Learn More
Neuro-Oncology
N/A
Enrolling
nct/study# N/A / NEURO-ONC-DATABASE
A Retrospective and Prospective Protocol to Evaluate Demographic and Clinical Outcomes in Neuro-Oncology Patients
Learn More
Neuro-Oncology
Phase II
Enrolling
nct/study# NCT06325683 / A072201
RANDOMIZED PHASE II TRIAL OF ANTI-LAG-3 AND ANTI-PD-1 BLOCKADE VS. SOC IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.